Atara Biotherapeutics GAAP EPS of $2.61 beats by $4.06, revenue of $120.8M (NASDAQ:ATRA)
Atara Biotherapeutics(US:ATRA) Seeking Alpha·2026-03-17 15:48Search fieldEntering text into the input field will update the search result belowEntering text into the input field will update the search result below ...